ATE435910T1 - Sumoylation-inhibitoren - Google Patents
Sumoylation-inhibitorenInfo
- Publication number
- ATE435910T1 ATE435910T1 AT03707041T AT03707041T ATE435910T1 AT E435910 T1 ATE435910 T1 AT E435910T1 AT 03707041 T AT03707041 T AT 03707041T AT 03707041 T AT03707041 T AT 03707041T AT E435910 T1 ATE435910 T1 AT E435910T1
- Authority
- AT
- Austria
- Prior art keywords
- tcf
- inhibitors
- sumoylation
- desumoylation
- agents
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57535—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the large intestine, e.g. colon, rectum or anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002055796 | 2002-03-01 | ||
| JP2002271527 | 2002-09-18 | ||
| PCT/JP2003/002029 WO2003074695A1 (fr) | 2002-03-01 | 2003-02-25 | Inhibiteurs de sumo |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE435910T1 true ATE435910T1 (de) | 2009-07-15 |
Family
ID=27790933
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03707041T ATE435910T1 (de) | 2002-03-01 | 2003-02-25 | Sumoylation-inhibitoren |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20050158808A1 (de) |
| EP (1) | EP1489169B1 (de) |
| JP (1) | JP4422490B2 (de) |
| AT (1) | ATE435910T1 (de) |
| AU (1) | AU2003211660A1 (de) |
| CA (1) | CA2477590A1 (de) |
| DE (1) | DE60328269D1 (de) |
| ES (1) | ES2326871T3 (de) |
| WO (1) | WO2003074695A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005051887A1 (de) * | 2005-10-29 | 2007-05-03 | Pemeas Gmbh | Membran für Brennstoffzellen, enthaltend Polymere, die Phosphonsäure-und/oder Sulfonsäuregruppen umfassen, Membran-Elektroden-Einheit und deren Anwendung in Brennstoffzellen |
| DE102005052378A1 (de) * | 2005-10-31 | 2007-05-03 | Pemeas Gmbh | Verbesserte Membran-Elektrodeneinheiten und Brennstoffzellen mit hoher Lebensdauer |
| KR101656104B1 (ko) * | 2010-05-13 | 2016-09-09 | 가톨릭대학교 산학협력단 | Ｐｉａｓ３을 유효성분으로 포함하는 암 또는 면역질환의 예방 또는 치료용 조성물 |
| WO2012064897A2 (en) * | 2010-11-09 | 2012-05-18 | Yuan Chen | Bicyclic and tricyclic inhibitors of sumoylation enzymes and methods for their use |
| CN103630691B (zh) * | 2012-08-24 | 2015-07-08 | 中国科学院深圳先进技术研究院 | 小泛素样修饰的生物检测方法 |
-
2003
- 2003-02-25 EP EP03707041A patent/EP1489169B1/de not_active Expired - Lifetime
- 2003-02-25 AT AT03707041T patent/ATE435910T1/de not_active IP Right Cessation
- 2003-02-25 ES ES03707041T patent/ES2326871T3/es not_active Expired - Lifetime
- 2003-02-25 AU AU2003211660A patent/AU2003211660A1/en not_active Abandoned
- 2003-02-25 WO PCT/JP2003/002029 patent/WO2003074695A1/ja not_active Ceased
- 2003-02-25 JP JP2003573146A patent/JP4422490B2/ja not_active Expired - Fee Related
- 2003-02-25 DE DE60328269T patent/DE60328269D1/de not_active Expired - Lifetime
- 2003-02-25 US US10/506,153 patent/US20050158808A1/en not_active Abandoned
- 2003-02-25 CA CA002477590A patent/CA2477590A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP4422490B2 (ja) | 2010-02-24 |
| EP1489169A4 (de) | 2006-07-05 |
| AU2003211660A1 (en) | 2003-09-16 |
| US20050158808A1 (en) | 2005-07-21 |
| EP1489169B1 (de) | 2009-07-08 |
| DE60328269D1 (en) | 2009-08-20 |
| CA2477590A1 (en) | 2003-09-12 |
| JPWO2003074695A1 (ja) | 2005-06-30 |
| ES2326871T3 (es) | 2009-10-21 |
| WO2003074695A1 (fr) | 2003-09-12 |
| EP1489169A1 (de) | 2004-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY25313A1 (es) | Inhibidores del dominio sh2 de la familia src | |
| BR9807674A (pt) | Inibidores bicìclicos da proteìna farnesil transferase | |
| ATE548354T1 (de) | Ureido-substituierte benzoesäureverbindungen und ihre verwendung für die nonsense-suppression und behandlung von erkrankungen | |
| ATE225772T1 (de) | Thrombin-inhibitoren | |
| DE502004004659D1 (de) | Verwendung von diphenylmethan-derivaten als tyrosinase-inhibitoren | |
| DE60312017D1 (de) | Sulfonderivate zur hemmung von gamma-secretase | |
| DK1427409T3 (da) | Fremgangsmåde til behandling eller forhindring af vaskulær inflammation under brug af en eller flere sterolabssorptionsinhibitorer | |
| ID27833A (id) | METODA UNTUK MENGOBATI ATEROSKLEROSIS DENGAN MENGGUNAKAN INHIBITOR aP2 DAN KOMBINASINYA | |
| DE60036540D1 (de) | Rho-kinase-inhibitoren für die vorbeugung oder behandlung von interstitieller pneumonie und pulmonaler fibrose | |
| TR199800773T2 (xx) | Trombin inhibit�rleri. | |
| BRPI0416268A (pt) | composições de delta-9-thc e métodos para o tratamento de sintomas associados à esclerose múltipla | |
| DK0946166T3 (da) | Anvendelse af matrixmetalloproteinaseinhibitorer til fremme af sårheling | |
| DE60220043D1 (de) | Carbamatverbindungen zur vorbeugung oder behandlung von neurodegenerativen störungen | |
| DE60120881D1 (de) | Sulfonamide als matrix-metalloproteinase inhibitoren | |
| DE60019321D1 (de) | Verfahren zum screening von inhibitoren von asp2 | |
| DE60139466D1 (de) | Behandlung von diabetes | |
| ATE435910T1 (de) | Sumoylation-inhibitoren | |
| DE602004004883D1 (de) | Vegf-antagonisten zur behandlung von diabetes | |
| ATE443044T1 (de) | Tace inhibitoren | |
| DE59900730D1 (de) | Korrosionsinhibitoren enthaltender Injektionszement | |
| ATE539756T1 (de) | Prostaglandinsubstanzen für die behandlung von fettsucht | |
| NO994041L (no) | Nye indan-l-ol forbindelser, en fremgangsmÕte for Õ behandle dem og farmasøytiske forbindelser inneholdende dem | |
| DE69330465D1 (de) | Verfahren zur behandlung von chronischer prostatitis mit 17-beta-n-tertbutylcarbamoyl-4-aza-5 alpha-androst-1-en-3-one | |
| ATE295168T1 (de) | Zusammensetzung von riluzol und alpha-tocopherol | |
| ATE333329T1 (de) | Vorrichtung zum überleiten oder einfädeln von bandanfängen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |